Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
CC transcript
Asset disposition
|
|
Cyclacel Pharmaceuticals, Inc. (CYCC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/17/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/16/2021 |
4/A
| Rombotis Spiro George (President and CEO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 190,000 options to buy
@ $3.45, valued at
$655.5k
|
|
| 04/12/2018 |
4/A
| Chiao Judy (V.P., Clin. Dev. & Reg. Aff.) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 5,668 shares
@ $0
Granted 20,000 shares
@ $0 |
|
| 11/20/2009 |
4/A
| Chiao Judy (V.P., Clin. Dev. & Reg. Aff.) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc. |
| 11/20/2009 |
4/A
| Rombotis Spiro George (President & C.E.O.) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc. |
| 01/08/2009 |
4/A
| Sosnowski Robert Edward (VP, Marketing & Sales) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc. |
|
|